The US Food and Drug Administration (FDA) has declined the approval of the first long-acting, monthly HIV drug called Cabenuva. The FDA said it declined the approval on the basis of concerns related to the manufacturing and control process, and not due to the safety and efficacy of the drug.

The post FDA Declines Approval of the First Long-Acting HIV Drug appeared first on Latest Health & Medical News – Myhealthyclick.com.